Hikal (HIKAL) — Board Meeting

📢 Key Event
Board approved unaudited financial results for Q1 FY2027 and reaffirmed environmental litigation status.

🔄 What Changed
Profit before tax shifted from ₹85 crores (Q1 FY2026) to ₹(75) crores (standalone) and ₹(100) crores (consolidated); exceptional items included ₹471 crores impairment and ₹89 crores employee benefit reversal.

🔮 What's Next
None

💡 Investor Takeaway
The company reported weaker quarterly profits with significant exceptional items and ongoing legal risks that may affect future performance.

Hikal Limited announced the outcome of its August 6, 2026 board meeting, approving unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The results show total income of ₹4,046 crores and profit before tax of ₹(75) crores for standalone operations, with consolidated revenue at ₹4,028 crores and profit before tax of ₹(100) crores. The board also addressed ongoing environmental litigation, USFDA warning letter impacts, and trading window restrictions.

📄 View Original Announcement (PDF)

📊 Stock Analysis — HIKAL ✨ Ask AI About This

About Hikal Limited (HIKAL)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹2,484.02 Cr P/E: 33.4

View full HIKAL stock details →

📡 Get AI alerts when HIKAL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track HIKAL — Free

💡 Ask AI about this filing

"How does the ₹471 crore impairment impact long-term crop protection segment profitability?" "What is the expected timeline for USFDA warning letter resolution affecting pharma segment sales?" "When will the trading window reopen for directors and senior management?"

Ask AI Free →

📊 More HIKAL filings

See all HIKAL filings →

🔥 Also filed on 6 August 2026

CHAMBLFERT Chambal Fertilizers & Chemicals Limited Financial Results SUMEETINDS Sumeet Industries Limited Financial Results VISAKAIND Visaka Industries Limited Corporate Action VISAKAIND Visaka Industries Limited Corporate Action SUNPHARMA Sun Pharmaceutical Industries Limited Financial Results VSTL Vibhor Steel Tubes Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when HIKAL files new disclosures

Track HIKAL filings, board meetings, and corporate actions. Free email alerts at 5 PM.